Delineating the Ligand–Receptor Interactions That Lead to Biased Signaling at the μ-Opioid Receptor

[Image: see text] Biased agonists, which selectively stimulate certain signaling pathways controlled by a G protein-coupled receptor (GPCR), hold great promise as drugs that maximize efficacy while minimizing dangerous side effects. Biased agonists of the μ-opioid receptor (μOR) are of particular in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Brendan, Hollingsworth, Scott A., Blakemore, David C., Owen, Robert M., Storer, R. Ian, Swain, Nigel A., Aydin, Deniz, Torella, Rubben, Warmus, Joseph S., Dror, Ron O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317888/
https://www.ncbi.nlm.nih.gov/pubmed/34251810
http://dx.doi.org/10.1021/acs.jcim.1c00585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317888/
https://www.ncbi.nlm.nih.gov/pubmed/34251810
http://dx.doi.org/10.1021/acs.jcim.1c00585

Ejemplares similares